Back to top
more

Encompass Health (EHC)

(Real Time Quote from BATS)

$108.53 USD

108.53
1,014,596

0.00 (0.00%)

Updated Aug 4, 2025 03:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Shaun Pruitt headshot

Here's Why Investors Should Buy These 2 Medical Stocks After Earnings

by Shaun Pruitt

Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.

Zacks Equity Research

Compared to Estimates, Encompass Health (EHC) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Encompass Health (EHC) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 28.38% and 2.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Acadia Healthcare's (ACHC) New Facility Boosts Pennsylvania Reach

by Zacks Equity Research

Acadia Healthcare (ACHC) commences operations at one of the two hospitals, which form a part of its JV with Geisinger. The company is committed to offer enhanced behavioral health services in Pennsylvania.

Zacks Equity Research

Here's Why Investors Should Add Encompass Health (EHC) to Portfolio

by Zacks Equity Research

Encompass Health (EHC) remains well-poised for growth on the back of solid demand for effective inpatient rehabilitation services, joint ventures and solid cash reserves.

Zacks Equity Research

Is DaVita (DVA) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Cigna (CI) to Add Three Biosimilars to NPF, Enable Cost Savings

by Zacks Equity Research

Cigna (CI) plans to integrate three cost-effective biosimilars within NPF in a bid to offer varied treatment options for Americans and solidify its pharmacy business.

Zacks Equity Research

Here's Why Encompass Health (EHC) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Here's Why Encompass Health (EHC) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Encompass Health's (EHC) 158th Hospital Opens in Maryland

by Zacks Equity Research

The Rehabilitation Hospital of Bowie is Encompass Health's (EHC) second location in the state of Maryland.

Zacks Equity Research

DaVita HealthCare (DVA) Down 1.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why Investors Should Hold Encompass Health (EHC) Now

by Zacks Equity Research

Encompass Health (EHC) remains well-poised for growth, attributable to expanding patient admissions, robust expansion endeavors and strong cash-generating abilities.

Zacks Equity Research

Encompass Health (EHC) to Build New Hospital in Concordville

by Zacks Equity Research

The new inpatient rehabilitation unit is likely to be the 10th hospital of Encompass Health (EHC) in Pennsylvania.

Zacks Equity Research

Why Encompass Health (EHC) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Encompass Health's (EHC) Q1 Earnings Beat, '23 EPS View Up

by Zacks Equity Research

Encompass Health's (EHC) Q1 results reflect improved patient volumes and higher discharge growth. Management estimates 2023 adjusted EPS within $2.94-$3.23, up from the earlier view of $2.87-$3.16.

Zacks Equity Research

Encompass Health (EHC) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 25.71% and 1.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Addus HomeCare (ADUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Are Investors Undervaluing Encompass Health (EHC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Earnings Preview: Encompass Health (EHC) Q1 Earnings Expected to Decline

by Zacks Equity Research

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

EHC vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

EHC vs. CHE: Which Stock Is the Better Value Option?

Zacks Equity Research

Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for OUSM

Zacks Equity Research

Encompass Health (EHC) Up 32% in 6 Months: More Room to Run?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of growing facility count within its Inpatient Rehabilitation segment and sound liquidity position.

Zacks Equity Research

Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for OUSM

Zacks Equity Research

Encompass Health (EHC) Soars 11.0%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Encompass Health (EHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Encompass Health (EHC) Opens JV Hospital for Oklahoma Patients

by Zacks Equity Research

Encompass Health (EHC) inaugurated the Owasso-based Ascension St. John Rehabilitation Hospital, that it will operate jointly with Ascension St. John to offer rehabilitative care in Oklahoma.